4-((5-Bromopyridin-2-yl)methyl)morpholine, 95.0%, 500mg

1,3,5-Triethylbenzene, 90.0%, 1g

N,N-Dimethyl-1-piperidin-4-ylmethanamine, 95.0%, 5g

1-(2-Methoxyphenyl)-4-(2-nitrophenyl)piperazine, 97%, 1g

5,5-Dimethyloxazolidine-2,4-dione, 97.00%, 500g

3-(ethoxycarbonyl)-1-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazole-5-carboxylic acid, 95.0%, 5g

Trial kit Spectra/Por® Biotech CE, 20000 dalton(s), 1 Piece(s)

3,4'-Difluorobenzophenone, 97.0%, 25g

2-(Methoxymethyl)-4-(trifluoromethyl)benzoic acid, 98%, 5g

5-Nitroquinazolin-4-ol, 95.0%, 5g

3-Chloro-2-methyl-6-nitrobenzoic acid, 95.0%, 250mg

2-(Trifluoromethyl)benzoic acid, 98.0%, 500g

2-(2-Chloro-5-nitrophenyl)acetic acid, 97%, 10g